James "Rev Shark" DePorre

|RSS

James "Rev Shark" DePorre is the author of Invest Like a Shark: How a Deaf Guy With No Job and Limited Capital Made a Fortune Investing in the Stock Market. He is founder and CEO of Shark Asset Management, an investment management firm, and he also operates sharkinvesting.com, an interactive online community that serves and educates active investors.Expand

DePorre holds business and law degrees from the University of Michigan, is a member of the Michigan Bar Association and a former attorney and CPA. He lives in Anna Maria Island, Fla., and Conover, N.C., with his wife and three children. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks.Collapse

By

James "Rev Shark" DePorre

 | Feb 12, 2016 | 4:06 PM EST

Action like this is always a bit frustrating for traders.

By

James "Rev Shark" DePorre

 | Feb 12, 2016 | 11:18 AM EST

The only really bullish argument right now is that sentiment is too negative.

By

James "Rev Shark" DePorre

 | Feb 12, 2016 | 7:15 AM EST

But remember that the way to make money is to buy trends, not bottoms.

By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 4:12 PM EST

Rumor on OPEC oil production cuts gives market a late lift.

By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 4:09 PM EST
I mentioned in my earlier comment to Doug Kass that I thought the algos would trigger the 1812 stops before we reversed. That is exactly what...

IWM

By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 1:51 PM EST
Dougie i don't trust that IWM has made a good low until i'm confident that SPY has bottomed. I still have serious doubts that the S&P500 is going...
By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 1:37 PM EST

You're better off waiting until equities have begun to bounce.

By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 11:35 AM EST

We will not likely see a bottom until the January lows are taken out.

By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 10:37 AM EST
The top three biotechnology picks we have at Shark Biotechnology right now are FGEN, RARE and BMRN
By

James "Rev Shark" DePorre

 | Feb 11, 2016 | 9:24 AM EST
So you believe we have seen a low that will hold for a fairly long period of time??

Judge Smails embarrassed me into writing it!

Some pretty obvious selling in the FATMAN names vs the Nasdaq futures post regular session...
You can see the time/price support on the daily chart of SPX below. It also shows you the ...

$185.80
Exhausted and a long weekend.
Column up shortly
Sold some IWM as well.

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.